Novavax jumps on positive flu vaccine results, while Acadia sinks on poor trials
Filed under: Company News , Healthcare , Novavax , Sanofi Aventis , Acadia Pharmaceuticals , Biovail Corp. Two weeks ago, Novavax ( NVAX ) shares soared some 10 percent after the small clinical-stage biotechnology company announced positive preclinical results for its new vaccine against H1N1 influenza. Shares jumped again today — this time about 15 percent by late-afternoon trading — after the vaccine maker announced positive results for its seasonal flu vaccine candidate in a mid













